Please select the option that best describes you:
What are your top takeaways in Classical Hematology from ASH 2025?
Answer from: at Academic Institution
The first and third are clinical practice-changing studies on the prevention of kidney disease. SGLT2 inhibitors will become very important in SCD. The second is on a promising new drug.Renin-angiotensin-aldosterone system inhibitors exacerbate anemia in sickle cell diseasePhase I study of the his...
Sign In or Register to read more
Answer from: at Academic Institution
My top 3 takeaways in classical hematology:1) ITP - much controversy at the education program session about the draft 2025 guidelines, where TPO mimetic + steroids is going to be recommended in the front line. There does not appear to be compelling new data that supports the revision of this guideli...